BSEBoard Meeting1h ago · 31 Oct 2026, 01:32 pm
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended on September 30, 2026
iSERA Lifesciences Ltd · 534920
✦ AI SummaryResults
iSERA Lifesciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/11/2026 to consider and approve the Un-Audited Financial Results for the quarter and half year ended on September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2026
Attachments (1)
📄pdf
Download →
790de8e8-2254-4554-9876-ed38ac8a7c3a.pdf
View document text
5 iSERA LIFESCIENCES
ISERA LIMITED
Date: 31/10/2026
The Listing Department
BSE Limited,
25th Floor, Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai, Maharashtra — 400001
REF: iSERA Lifesciences Limited (Formerly Known as Covidh Technologies Limited)
(Scrip Code: 534920) | Symbol: COVIDH)
SUBJECT:
Information under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 regarding consideration of the Standalone Un-Audited Financial Results for
the quarter and half year ended on September 30, 2026.
The SEBI (Prohibition of Insider Trading) Regulations, 2015 - Closure of Trading Window
announced with effect from October 01, 2026 until completion of 48 hours after declaration of
the Un-Un-Audited Financial Results of the Company for the quarter and half year ended on
September 30, 2026.
Any Other matter with the permission of the Chaiman.
Dear Sir/Madam,
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice
is hereby given that the meeting of the Board of Directors of the Companiys scheduled to be held on 4, November
2026 inter-alia, to consider, approve and take on record the Un-Audited Financial Results of the Company for
the quarter and half year ended on September 30, 2026
Further, in terms of provisions of SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the
Trading Window for dealing in the Equity Shares of the Company shall remain closed for all designated persons,
for the period from, Thursday October 01, 2026 and end 48 hours after the results are made public for the
quarter and Half year ended on September 30, 2026.
The said notice may be accessed on the Company’s website at https://covidhtechnologies.com
and may also be accessed on the Stock Exchanges website at https://bseindia.com
You are requested to please take on record our above said information for your reference.
Thanking you.
Yours faithfully,
For and on behalf of
iSERA Lifesciences Limited (Formerly Known as Covidh Technologies Limted)
Deepakshi
Company Secretary and Compliance Officer
M. No. 76335
Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune — 411001
Tel: +918329012053 + Email: cscovidh@gmail.com - Website: www.covidhtechnologies.com